Targeted delivery of antisense oligodeoxynucleotides by LPDII

Journal of Liposome Research

Volumn 7, Issue 1, 1997, Pages 63-75

  Li, Song ^a   Huang, Leaf ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL HYDROGEN SUCCINATE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR; FOLATE BINDING PROTEIN; LIPOSOME; LIPOSOME LPD2; OLIGODEOXYNUCLEOTIDE; POLYLYSINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; DRUG TARGETING; EXPRESSION VECTOR; GROWTH INHIBITION; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0031048069     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109709035482     Document Type: Article

References (30)

1. Cohen, J.S. 1991. Antisense oligonucleotides as antiviral agents. Antiviral Res. 16: 121.
2. Cooke, S.T. 1992. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32: 329.
3. Stein, C.A., and Cheng, Y.-C. 1993. Antisense oligonucleotides as therapeutic agents-is the bullet really magical? Science 261:1004.
4. Milligan, J.F., Matteucci, M.D., and Martin, J.C. 1993. Current concepts in antisense drug design. J. Med. Chem. 36: 1923.
5. Yakubov, L.A., Deeva, E.A., Zarytova, V.F., Ivanova, E.M., Ryte, A.S., Yurchenko, L.V., and Vlassov, V.V. 1989. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci, USA 86: 6454.
6. Stein, C.A., Subasinghe, C., Shinozuka, K., and Cohen, J.S. 1988. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16: 3209.
7. Akhtar, S., Basu, S., Wickstrom, E., and Juliano, R.L. 1991. Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucleic Acids Res. 19: 5551.
8. Loke, S.L., Stein, C.A., Zhang, X.H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J.S., and Neckers, M. 1989. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86: 3474.
9. Wu, G.Y., and Wu, C.H. 1992. Specific inhibition of hepatitis B viral gene expression by targeted antisense oligonucléotides. J. Biol. Chem. 267: 12436.
10. Citro, G., Szczylik, C., Zupi, G., and Calabretta, B. 1994. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Br. J. Cancer 69: 463.
11. Ropert, C., Okruszek, A., Couvreur, P., and Malvy, C. 1994. Retroviral inhibition by antisense oligonucléotides determined by intracellular stability. Antisense Res. Dev. 4: 207.
12. Wang, S., Lee, R.J., Cauchon, G., Gorenstein, D.O., and Low, P.S. 1995. Delivery of antisense oligodeoxyribonucleotides against human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA 92: 3318.
13. Bennett, C.F., Chaing, M.-Y., Chan, H., Shoemaker, J.E.E., and Mirabelli, C.K. 1992. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucléotides. Mol. Pharmacol. 41:1023.
14. Lappalainen, K., Urtti, A., Soderling, E., Jaaskelainen, I., Syrjanen, K., and Syrijanen, S. 1994. Cationic liposomes improve stability and intracellular delivery of antisense oligonucléotides into Caski cells. Biochim. Biophys.Acta 1196: 201.
15. Cumin, F., Asselbergs, F., Lartigot, M., and Felder, E. 1993. Modulation of human protein gene expression by antisense oligonucléotides in transfected CHO cells. Eur. J. Biochem. 212: 347.
16. Lizinger, D.C., Brown, J.M., Wala, I., Kaufman, S.A., Van, G.Y., Farrell, C.L., and Collins, D. 1996. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim. Biophys. Acta 1281:139.
17. Lewis, J.G., Lin, K.-Y., Kothavale, A., Flanagan, W.M., Matteucci, M.D., Deprrince, R.B., Mook, Jr. R.A., Hendern, R.W., and Wagner, R.W. 1996. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93: 3176.
18. Lee, R.J., and Huang, L. 1996. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271: 8481.
19. Kamen, B.A., Wang, M.-T., Streckfuss, A.J., Peryea, X., and Anderson, R.G.W. 1988. Delivery of folates to the cytoplasm of MA 104 cells is mediated by a surface membrane receptor that recycles. J. Biol. Chem. 263: 13602.
20. Kane, M.A., Elwood, P.C., Portillo, R.M., Antony, A.C., and Kolhouse, J.F. 1986. The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells. J. Biol. Chem. 261:15625.
21. Mayor, S., Rothberg, K.G., and Maxfield, F.R. 1994. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science 264: 1948.
22. Coney, L.R., Tomassetti, A., Carayannopoulos, L., Frasca, V., Kamen, B.A., Colnaghi, M.I., and Zurawski, V.R., Jr. 1991. Cloning of tumorassociated antigen: MOvlS and MOvl9 antibodies recognize a folate-binding protein. Cancer Res. 51: 6125.
23. Leamon, C.P., and Low, P.S. 1992. Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267:24966.
24. Lee, R.J., and Low, P.S. 1995. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233: 134.
25. Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tarn, A.W., Lee, J., Yarden, Y., Libermann, T.A., and Schlessinger, J. 1984. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418.
26. Xu, Y.H., Richert, N., Ito, S., Merlino, G.T., and Pastan, I. 1984. Characterization of epidermal growth factor gene expression in malignant and normal cell lines. Proc. Natl. Acad. Sci. USA 81:7308.
27. Carpenter, G., and Cohen, S. 1990. Epidermal growth factor. J. Biol. Chem. 265: 7709.
28. Hunter, T. 1991. Cooperation between oncogenes. Cell. 64: 249.
29. Moroni, M.C., Willingham, M.C., and Beguinot, L. 1992. EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. J. Biol. Chem. 267: 2714.
30. Fakler, B., Herlitz, S., Amthor, B., Zenner, H.P., and Ruppersberg, J.P. 1994. Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo length and concentration but almost independent of localization of the target sequence. J. Biol. Chem. 269:16187.